ImageneBio (IMA) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Initiated Coverage | Buy | $28.00 | Aug 21, 2026 |
| Wedbush | Maintained | Underperform | $2.00 | May 11, 2026 |
| Wedbush | Initiated Coverage | Underperform | $2.00 | Nov 25, 2025 |
| Leerink Partners | Initiated Coverage | Outperform | $30.00 | Oct 24, 2025 |
| Wedbush | Maintained | Neutral | $23.00 from $25.00 | Jul 25, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Nov 11, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Aug 12, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 from $11.00 | May 29, 2024 |
| Wedbush | Downgraded | Outperform → Neutral | $2.00 from $8.00 | May 29, 2024 |
| Wedbush | Maintained | Outperform | $8.00 | May 14, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Mar 19, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Mar 12, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Jan 19, 2024 |
| Wedbush | Maintained | Outperform | $8.00 | Jan 19, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $18.00 | Nov 9, 2023 |
| Wedbush | Initiated Coverage | Outperform | $11.00 | Sep 22, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | Aug 10, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | Aug 7, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | May 24, 2023 |
| Credit Suisse | Maintained | Outperform | $13.00 | May 16, 2023 |
Frequently asked questions
Is IMA a buy, sell, or hold?
Analysts covering ImageneBio currently average a Buy rating: 3 buy, 0 hold and 1 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on IMA?
On Aug 21, 2026, HC Wainwright & Co. initiated coverage of ImageneBio at Buy with a price target of $28.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.